ROS-major mediators of extracellular matrix remodeling during tumor progression

被引:61
|
作者
Nikitovic, Dragana [1 ]
Corsini, Emanuela [2 ]
Kouretas, Dimitrios [3 ]
Tsatsakis, Aristidis [4 ]
Tzanakakis, George [1 ]
机构
[1] Univ Crete, Sch Med, Dept Histol Embryol, Iraklion 71003, Greece
[2] Univ Milan, Toxicol Lab, DiSFeB, I-20122 Milan, Italy
[3] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece
[4] Univ Crete, Dept Forens Sci & Toxicol, Iraklion 71003, Greece
关键词
Tumor; Metastasis; Extracellular matrix; ROS; Glycosaminoglycans; Matrix metalloproteinases; EPITHELIAL-MESENCHYMAL TRANSITION; ACTIVATOR RECEPTOR EXPRESSION; BREAST-CANCER CELLS; GROWTH-FACTOR-BETA; REACTIVE OXYGEN; OXIDATIVE STRESS; NITRIC-OXIDE; PLASMINOGEN-ACTIVATOR; FREE-RADICALS; NADPH OXIDASE;
D O I
10.1016/j.fct.2013.06.013
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Extracellular matrices (ECMs) represent a complex network of proteins, proteoglycans and glycosaminoglycans (GAGs), composed of independent structural domains, ultimately constituting the cell microenvironment. As a highly organized, insoluble suprastructure, the ECM can, in a spatially patterned and regulated manner, integrate and deliver multiple complex signals to cells that affect their behavior. During the progression of carcinogenesis, tumor cells, through a continually changing interface, remodel and simultaneously interact with the components of ECM, as well as with surrounding stromal cells. Within this complex network of ECM components affecting tumor progression, reactive oxygen species/reactive nitrogen species (ROS/RNS) play a wide emerging role. In this minireview we will focus on the ROS-dependent modulations of tumor ECM and how this in turn affects the insidious pathways of tumor progression and dissemination. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:178 / 186
页数:9
相关论文
共 50 条
  • [11] Extracellular matrix remodeling in the tumor immunity
    Du, Wei
    Xia, Xueming
    Hu, Fan
    Yu, Jiayun
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [12] The extracellular matrix in tumor progression and metastasis
    Johannes A. Eble
    Stephan Niland
    Clinical & Experimental Metastasis, 2019, 36 : 171 - 198
  • [13] The extracellular matrix in tumor progression and metastasis
    Eble, Johannes A.
    Niland, Stephan
    CLINICAL & EXPERIMENTAL METASTASIS, 2019, 36 (03) : 171 - 198
  • [14] Extracellular matrix remodeling during morphogenesis
    Werb, Z
    Chin, JR
    MORPHOGENESIS: CELLULAR INTERACTIONS, 1998, 857 : 110 - 118
  • [15] Extracellular Vesicles and Matrix Remodeling Enzymes: The Emerging Roles in Extracellular Matrix Remodeling, Progression of Diseases and Tissue Repair
    Nawaz, Muhammad
    Shah, Neelam
    Zanetti, Bruna Riedo
    Maugeri, Marco
    Silvestre, Renata Nacasaki
    Fatima, Farah
    Neder, Luciano
    Valadi, Hadi
    CELLS, 2018, 7 (10)
  • [16] Remodeling of the extracellular matrix during decidualization
    San Martín, S
    PLACENTA, 2006, 27 (01) : A31 - A31
  • [17] New insights into the role of extracellular matrix during tumor onset and progression
    Pupa, SM
    Ménard, S
    Forti, S
    Tagliabue, E
    JOURNAL OF CELLULAR PHYSIOLOGY, 2002, 192 (03) : 259 - 267
  • [18] Remodeling of extracellular matrix due to solid stress accumulation during tumor growth
    Pirentis, Athanassios P.
    Polydorou, Christiana
    Papageorgis, Panagiotis
    Voutouri, Chrysovalantis
    Mpekris, Fotios
    Stylianopoulos, Triantafyllos
    CONNECTIVE TISSUE RESEARCH, 2015, 56 (05) : 345 - 354
  • [19] Extracellular matrix remodeling during the progression of volume overload-induced heart failure
    Hutchinson, Kirk R.
    Stewart, James A., Jr.
    Lucchesi, Pamela A.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2010, 48 (03) : 564 - 569
  • [20] Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression
    Alexandra Fullár
    József Dudás
    Lászlóné Oláh
    Péter Hollósi
    Zoltán Papp
    Gábor Sobel
    Katalin Karászi
    Sándor Paku
    Kornélia Baghy
    Ilona Kovalszky
    BMC Cancer, 15